MILLENDO THERAPEUTICS INC's ticker is MLND and the CUSIP is 60040X103. A total of 58 filers reported holding MILLENDO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $64,000 | -26.4% | 53,097 | +0.0% | 0.01% | -16.7% |
| Q3 2020 | $87,000 | -6.5% | 53,093 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $93,000 | -59.7% | 53,093 | +21.3% | 0.01% | -61.5% |
| Q1 2020 | $231,000 | -34.2% | 43,769 | -15.9% | 0.01% | -7.1% |
| Q4 2019 | $351,000 | -7.6% | 52,032 | -2.6% | 0.01% | 0.0% |
| Q3 2019 | $380,000 | -38.5% | 53,419 | 0.0% | 0.01% | -36.4% |
| Q2 2019 | $618,000 | +187.4% | 53,419 | +273.2% | 0.02% | +214.3% |
| Q1 2019 | $215,000 | -49.4% | 14,314 | -73.2% | 0.01% | -56.2% |
| Q4 2018 | $425,000 | – | 53,422 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,396,615 | $9,930,000 | 3.10% |
| NEA Management Company, LLC | 1,766,779 | $12,562,000 | 1.04% |
| Samsara BioCapital, LLC | 186,540 | $1,326,000 | 0.90% |
| GREAT POINT PARTNERS LLC | 1,288,093 | $9,158,000 | 0.84% |
| Bpifrance SA | 1,078,670 | $7,669,000 | 0.83% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,825 | $1,264,000 | 0.58% |
| ADAMS STREET PARTNERS LLC | 367,935 | $2,616,000 | 0.52% |
| Prosight Management, LP | 52,051 | $370,000 | 0.20% |
| GMT CAPITAL CORP | 53,419 | $380,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 38,881 | $276,000 | 0.00% |